Search
Main Menu
Main Content
Fermer
Choose language
FR
EN
Accessibility
Change contrast :
Standards
Reinforced
icone
HAS profile
Mission
Organisational Structure
Ethics, transparency and management of conflicts of interest
International relations and projects
Publications
English content
Medicines
Opinions on medical devices
INAHTA briefs
French website
Chercher
Recherche
icone plus
English content
Les recommandations et guides
Les médicaments
Les actes professionnels
Les dispositifs médicaux
Les médecins accrédités
Les articles d'information
Les établissements de santé
Chercher
My account
My account
Email alert Subscription
Newsletter Subscription
My search
Refresh
Please fill in your email address to retrieve your email alerts subscriptions.
New subscription
Please fill in your email address to retrieve your newsletter subscriptions.
You do not have a saved search
Sélection
No element in selection
Contact
4 results
Active substance : fer
Topics : Congenital, genetic and rare diseases
+
Chercher
Filter
Topic
Diseases and conditions
(4)
Plus ...
Congenital, genetic and rare diseases
(4)
Digestive system diseases
(3)
Plus ...
Liver diseases
(2)
Pancreatic and biliary tract diseases
(1)
Endocrine system and metabolic diseases
(3)
Plus ...
Metabolic diseases
(3)
Respiratory tract diseases
(1)
Plus ...
Pulmonary and pleural diseases
(1)
Economics and public health
(1)
Plus ...
Health economics
(1)
Screening, prevention
(1)
Population groups
(1)
Plus ...
Paediatrics
(1)
Content type
Practice Guidelines and Other Guides
(4)
Plus ...
Practice guidelines
(2)
Chronic disease guide
(1)
Public Health guideline
(1)
Manufacturer
industriels
(1)
Language
Français
(4)
Active substance
alanine
(2)
alcool
(2)
aluminium
(1)
arginine
(1)
aspirine
(1)
chlorure de sodium
(1)
cuivre
(1)
fer
(4)
fer ferreux
(1)
fer ferrique
(1)
fructose
(1)
glycine
(1)
histidine
(1)
insuline glargine
(1)
lysine
(1)
miglustat
(1)
sodium
(1)
taurine
(1)
tryptophane
(1)
tyrosine
(1)
zinc
(3)
Save your search
Practice guidelines and other guides
- 4 results
Gaucher disease
Chronic disease guide
- Posted on 11/5/2007
Download
guide
Add to
my selection
Management of patients with HFE-related haemochromatosis (Type 1 haemochromatosis)
Practice guidelines
- Posted on 1/7/2005
Download
abstract
Add to
my selection
Clinical and economic assessment of screening for HFE1 haemochromatosis in 2004
Public Health guideline
- Posted on 1/4/2004
Download
abstract
Add to
my selection
See 4 result in Practice Guidelines and Other Guides
Français
English
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
tbmJ1KaZZrrQg5t8
Français